ECM
JANX icon

ExodusPoint Capital Management’s Janux Therapeutics JANX Stock Holding History

ExodusPoint Capital Management’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.59M Sell
114,572
-46,976
-29% -$644K 0.01% 858
2025
Q4 		$2.23M Buy
+161,548
New +$3.8M 0.02% 732
2025
Q3 		– Sell
-74,715
Closed -$1.73M – 1772
2025
Q2 		$1.73M Buy
74,715
+46,751
+167% +$1.23M 0.02% 796
2025
Q1 		$755K Buy
+27,964
New +$1.05M 0.01% 995
2024
Q4 		– Sell
-6,413
Closed -$291K – 1768
2024
Q3 		$291K Buy
+6,413
New +$279K ﹤0.01% 1369
2021
Q3 		– Sell
-24,567
Closed -$613K – 2382
2021
Q2 		$613K Buy
+24,567
New +$547K 0.01% 1255

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return